Study linking malaria resurgence, reduction in malaria control programs highlights need for sustained funding

NewsGuard 100/100 Score

"Progress in eradicating malaria is jeopardized if programs to combat the disease are cut," a study published in the Malaria Journal on Tuesday concluded, according to a BMJ news article. The study "looked at 75 documented cases of malaria resurgence worldwide since the 1930s" and "found that in 90 percent of the cases, resurgence was linked, in part, to weakening of malaria control programs," the article states. "The study warns: 'Today, the threat of resurgence again looms as constrained global funding and competing priorities threaten the sustainability of successes,'" and it "highlights brief increases in the incidence of malaria in some countries, including Rwanda and Zambia, as a matter for concern," BMJ notes (Gulland, 4/24).

The study, which is allied to the theme of Wednesday's World Malaria Day, "Sustain Gains, Save Lives: Invest in Malaria," "found that the most common reason for weakening of malaria control programs was funding disruptions," a BioMed Central press release states (4/23). In an accompanying Malaria Journal commentary (.pdf), Robert Newman, director of the WHO's Global Malaria Programme, writes, "Their findings are timely and compelling, demonstrating that global efforts will be wasted if the resources ... required to achieve and maintain universal access to life-saving malaria prevention and control tools" are not secured. He concludes, "The increases in funding for malaria over the past decade, while impressive, still fall far short of the nearly $6 billion required annually. ... However, with sufficient support, malaria resurgences can be relegated to history" (4/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials